CRP and head and neck cancer: In head and neck cancers, the neutrophil-to-lymphocyte ratio7, albumin level, and C-reactive protein level in the blood have recently attracted attention as biomarkers for the prediction of therapeutic efficacy and prognosis but are currently used only for reference.